ConductScience.org, home

Trial · NCT02185456

Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis

NCT02185456, Early phase 1, Unknown, Wayne State University

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis. Trials, record NCT02185456. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02185456

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Validation of a Novel Diagnostic, Prognostic Assay for Bacterial Vaginosis
NCT number
NCT02185456
Status
Unknown
Phases
Early phase 1
Enrollment
200 participants, estimated
Lead sponsor
Wayne State University
Conditions
Bacterial Vaginosis
Interventions
750 mg metronidazole/ 200 mg miconazole vaginal suppository, Standard of care
First posted
2014-07-09
Last updated
2014-11-07

Source ClinicalTrials.gov

Registered outcomes2

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryDiagnosis of bacterial vaginosisMonthly for up to nine monthsPatients and control women will be assessed monthly for bacterial vaginosis by Nugent and Amsel criteria
SecondaryRelative quantity of Lactobacillus among total vaginal bacteriaMonthly clinical visits and daily swabs for up to nine months
This quantitative assay of relative Lactobacillus content of vaginal swabs will be assessed monthly by qPCR, from samples taken at the clinic and from daily self swabs. This will be reported as a score, which is proportional to percentage Lactobacillus, and also integrates a score which reflects the prevalence of mid to low levels of non-Lactobacillus species.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers4

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
23624483BACKGROUNDPubMed
23994951BACKGROUNDPubMed
24376552BACKGROUNDPubMed
24722380BACKGROUNDPubMed

Grants1

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal years
R21AI111103Validation of a novel diagnostic, prognostic assay for bacterial vaginosisAKINS, ROBERT AWAYNE STATE UNIVERSITYNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES2014 to 2015

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT02185456

GET https://conductscience.org/api/trials/v1/NCT02185456/registered